Bevacizumab/Mirvetuximab Soravtansine Regimen

Preferred Label : Bevacizumab/Mirvetuximab Soravtansine Regimen;

NCIt synonyms : Bevacizumab/Mirvetuximab Soravtansine-gynx; Avastin/Elahere; Elahere/Avastin; Mirvetuximab Soravtansine-gynx/Bevacizumab; Bevacizumab/Mirvetuximab Soravtansine; Mirvetuximab Soravtansine/Bevacizumab; Mirvetuximab Soravtansine/Bevacizumab Regimen; Bevacizumab-Mirvetuximab Soravtansine; Mirvetuximab Soravtansine-Bevacizumab; Avastin/Elahere Regimen; Bevacizumab/Mirvetuximab Soravtansine-gynx Regimen; Bevacizumab Plus Mirvetuximab Soravtansine; Bevacizumab Plus Mirvetuximab Soravtansine-gynx;

NCIt definition : A regimen consisting of bevacizumab and mirvetuximab soravtansine that can be used for the treatment of ovarian, fallopian tube, and primary peritoneal cancer.;

NCI Metathesaurus CUI : CL1913050;

Details

Origin ID

C192897;

UMLS CUI

C5785496;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bevacizumab [NCIt concept]
- Mirvetuximab Soravtansine [NCIt concept]
concept_is_in_subset
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients